| Previous Close | 37.15 |
| Open | 37.25 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 36.93 - 37.32 |
| 52 Week Range | 29.82 - 38.78 |
| Volume | 3,383,822 |
| Avg. Volume | 4,622,774 |
| Market Cap | 35.64B |
| Beta | 0.22 |
| PE Ratio (TTM) | 19.63 |
| EPS (TTM) | 1.89 |
| Earnings Date | Oct 24, 2017 - Oct 30, 2017 |
| Dividend & Yield | 1.31 (3.51%) |
| Ex-Dividend Date | 2017-08-11 |
| 1y Target Est | 41.19 |
- Barrons.com•2 days ago
Diversified Utilities Offer 'Attractive Value' In Bargains-Starved Sector
Some of the diversified utilities have lagged lately, but Morgan Stanley’s Stephen Byrd and his team thinks that that trend could soon reverse. Byrd writes that Exelon Corp (EXC), Entergy Corp (ETR), Public Service Enterprise Group (PEG), and FirstEnergy Corp (FE) have underperformed their regulated peers by about 10% year to date. Byrd argues that the group’s valuation is attractive, and in general prefers the diversified utilities to the regulated ones.
Markit•2 days agoSee what the IHS Markit Score report has to say about Exelon Corp.
Exelon Corp NYSE:EXC
- Market Realist•3 days ago
How Did Novartis’s Established Medicines Perform in 1H17?
In 1H17, Novartis’s (NVS) Galvus generated revenues of around $596 million compared to $589 million in 1H16.
